Article Versions Notes

Schemmert S, Camargo LC, Honold D, Gering I, Kutzsche J, Willuweit A, Willbold D. In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 2021; 22(12):6553. https://doi.org/10.3390/ijms22126553

Schemmert, Sarah, Luana Cristina Camargo, Dominik Honold, Ian Gering, Janine Kutzsche, Antje Willuweit, and Dieter Willbold. 2021. "In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease" International Journal of Molecular Sciences 22, no. 12: 6553. https://doi.org/10.3390/ijms22126553

Schemmert, S., Camargo, L. C., Honold, D., Gering, I., Kutzsche, J., Willuweit, A., & Willbold, D. (2021). In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 22(12), 6553. https://doi.org/10.3390/ijms22126553